Skip to main content
SpringerLink
Log in

Birkenpollenallergie: SLIT-Präparat effektiv nach EAACI-Kriterien

  • Literatur kompakt
  • Published:
Allergo Journal Aims and scope Submit manuscript

Eine Birkenpollenallergen-Lösung zur sublingualen Immuntherapie reduziert bei Patienten mit mäßiger bis schwerer birkenpollenassoziierter Rhinokonjunktivitis die Symptomlast entsprechend den EAACI-Kriterien und ist sicher. Das zeigt eine neue Phase-III-Studie.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Pfaar O et al. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma. J Allergy Clin Immunol 2019;143:970–7

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Barbara Kreutzkamp

Authors
  1. Barbara Kreutzkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kreutzkamp, B. Birkenpollenallergie: SLIT-Präparat effektiv nach EAACI-Kriterien. Allergo J 28, 12–13 (2019). https://doi.org/10.1007/s15007-019-1826-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15007-019-1826-9

Search

Navigation